Malaria patient provides a blood sample.
Scientists Describe Malaria Drug Resistance
In two studies appearing online today in Science, international research teams including NIAID scientists describe how certain genetic mutations make malaria-causing parasites resistant to artemisinin, the first-line drug for treating the disease. Their results promise to aid development of new strategies to counter the threat that artemisinin resistance poses to global malaria control and elimination.
No hay comentarios:
Publicar un comentario